Why AI Is the Future of the Healthcare Industry
- 3 hours ago
- 6 min read
AI in healthcare is growing rapidly, backed by real, verifiable numbers: the FDA has authorised 1,451 AI-enabled medical devices as of the end of 2025, and 63% of US physicians reported using AI tools by January 2026, up from 47% just nine months earlier. Most current clinical AI focuses on diagnostics and imaging, not generative AI. No FDA-cleared device yet runs on a large language model.
Introduction
"AI is the future of healthcare" gets said a lot, often without much behind it. So instead of repeating the claim, we wanted to check it against real, current data: FDA records, physician surveys, and verified market activity.
What we found is a genuinely strong case, but a more specific and grounded one than the hype usually suggests. AI in healthcare isn't a single, futuristic breakthrough. It's a fast-growing set of tools already being used in diagnostics, documentation, and drug development, with clear regulatory and adoption trends backing it up.
In this guide, we'll walk through the real numbers behind AI in healthcare, where it's already making a measurable difference and where it honestly still falls short.
The Numbers Behind AI in Healthcare Right Now
A few figures stand out because they're independently verifiable, not just projections:
The FDA has authorised 1,451 AI-enabled medical devices as of the end of 2025, up from 692 in 2023, more than double in two years, according to an analysis of the FDA's own published device list.
76% of these devices (1,104) are in radiology, making medical imaging by far the most mature clinical application of AI.
63% of US physicians reported using AI tools between November 2025 and January 2026, according to a Doximity survey, up sharply from 47% in March 2025.
295 AI/ML devices were cleared by the FDA in 2025 alone, the highest single-year total on record.
As of March 2026, no FDA-authorized medical device runs on generative AI or a large language model. Nearly all cleared devices use more traditional, narrower machine learning models.
That last point matters. The "AI in healthcare" most people picture- a conversational AI assistant helping with diagnosis- isn't what's actually been cleared for clinical use yet. What's driving real adoption today is more specific and more established than that.
Market size estimates for AI in healthcare vary significantly between research firms, ranging from roughly $24 billion to $56 billion for 2026 depending on scope and methodology. What's consistent across nearly every estimate is the growth rate: most analysts project a compound annual growth rate in the 30-40% range through the early 2030s.
Why AI in Healthcare Is Growing So Fast
A few consistent drivers show up across the data:
Workforce shortages - healthcare systems are under real staffing pressure, and AI tools that reduce administrative or diagnostic workload address a genuine capacity gap
Rising clinical complexity - more data per patient (imaging, labs, records) than clinicians can manually review at scale
Regulatory support - agencies like the FDA and the UK's MHRA have expanded dedicated pathways and funding for AI medical device review
Proven ROI in specific use cases - imaging AI and administrative automation have measurable track records, which builds the case for further investment
Where AI in Healthcare Is Already Making a Difference
Medical Imaging and Diagnostics
This is the most mature application by far, backed by the FDA data above. AI tools assist radiologists in detecting abnormalities in X-rays, CT scans, and MRIs, generally as a supporting second read, not a replacement for the radiologist's judgment.
Clinical Documentation and Administrative Relief
Ambient AI documentation tools, which listen to and summarise clinical conversations, have seen rapid adoption. Industry surveys report that the large majority of major health systems now use some form of AI-assisted documentation, addressing one of the most common sources of physician burnout: paperwork.
Drug Discovery and Development
AI is increasingly used to identify potential drug candidates and predict molecular behaviour earlier in the research process, an area where pharmaceutical companies have invested heavily.
Predictive Analytics and Early Detection
Hospitals are using AI models integrated with electronic health records to flag patients at risk of complications or readmission. Reported hospital adoption of predictive AI tied to EHRs has grown from around two-thirds to over 70% of US non-federal acute-care hospitals in recent years.
Virtual Health Assistants and Patient Engagement
Chatbots and virtual assistants are commonly used for appointment scheduling, triage questions, and basic patient communication, reducing administrative load on staff. Industry surveys have identified this as a leading area for near-term return on investment.
Robot-Assisted Surgery
AI-assisted robotic surgical systems continue to expand, primarily in precision-focused procedures where AI supports (rather than replaces) the surgeon's control.
What AI in Healthcare Can't Do Yet
It's worth being direct about this, since overstating AI's current role in healthcare undermines trust in the genuinely real progress:
No FDA-cleared device currently uses generative AI or large language models. Most clinical AI in active use is narrower, purpose-built machine learning, not conversational AI.
AI tools support clinical judgment; they don't replace it. Every major deployment reviewed here operates as a decision-support tool, with a human clinician making the final call.
Evidence quality varies. Regulatory researchers have flagged that a meaningful portion of authorized AI devices lack extensive published clinical evidence, which is part of why ongoing monitoring and regulation continue to evolve.
The Regulatory Side of AI in Healthcare
Because AI in healthcare directly affects patient outcomes, regulation is tightening, not loosening. The FDA has introduced frameworks like Predetermined Change Control Plans (PCCP) to manage how AI models can be updated post-approval, and international efforts, including the EU AI Act's high-risk system requirements phasing in through 2026-2027, are adding further oversight specifically for healthcare AI applications.
This is a genuinely positive sign for the industry's long-term credibility, more structured regulation tends to build clinical trust, not slow adoption.
How iView Labs Supports AI in Healthcare
At iView Labs, we build AI-powered software for healthcare and healthtech businesses, with an emphasis on the structure and governance this space genuinely requires.
Our approach includes:
AI application development for healthcare and healthtech platforms
AI model testing and integration, with attention to data privacy and accuracy
Custom software development for patient-facing and clinical-support tools
Secure, compliant architecture for handling sensitive health data
With 13+ years of experience, we've worked with international clients across the US, UK, Australia, and beyond, including projects across healthcare, fintech, healthtech, education, and e-commerce. In healthcare specifically.
We've delivered projects for clients across the United States, Canada, Israel, UK, Australia, and Switzerland. We're also ISO 9001:2015 certified, reflecting the structured, auditable approach that healthcare software development requires.
You can view our work here: https://www.iviewlabs.com/our-portfolio
If you're building AI-powered software for healthcare or healthtech, contact iView Labs. Our team can help you build with both innovation and compliance in mind.
Conclusion
AI in healthcare is growing on real, measurable ground, not just hype. FDA authorizations have more than doubled since 2023, physician adoption jumped sharply in less than a year, and imaging, documentation, and predictive analytics all have genuine track records now.
At the same time, the honest picture is more specific than "AI will run healthcare." Today's clinical AI is narrow, purpose-built, and used to support human clinicians, not replace them, and generative AI hasn't yet reached FDA-cleared clinical devices. That distinction matters, and it's exactly why the current growth is credible rather than speculative.
Frequently Asked Questions
Q1. How many AI medical devices has the FDA authorized?
As of the end of 2025, the FDA had authorized 1,451 AI-enabled medical devices, with 76% (1,104) in radiology, according to analysis of the FDA's published AI/ML device list.
Q2. What percentage of doctors use AI in healthcare?
According to a Doximity survey, 63% of US physicians reported using AI tools between November 2025 and January 2026, up from 47% in March 2025.
Q3. Does AI in healthcare use generative AI or ChatGPT-like tools?
As of March 2026, no FDA-authorized medical device uses generative AI or a large language model. Most current clinical AI relies on narrower, purpose-built machine learning models, primarily in imaging and diagnostics.
Q4. What is the most established use of AI in healthcare today?
Medical imaging and diagnostics are the most mature applications of AI in healthcare, accounting for most FDA-authorized AI medical devices.
Q5. Does AI in healthcare replace doctors?
No. Current AI in healthcare functions as a decision-support tool. Every major deployment reviewed in current research still relies on a human clinician to make the final clinical decision.
Q6. Is AI in healthcare regulated?
Yes. Regulatory oversight is expanding, including the FDA's Predetermined Change Control Plan framework and the EU AI Act's high-risk system requirements, both aimed at ensuring safe, monitored deployment of AI in clinical settings.
Q7. Can iView Labs build AI-powered healthcare software?
Yes. iView Labs builds AI-powered applications for healthcare and healthtech businesses, with experience across international clients and a focus on secure, compliant development.
Comments